Neurological Disorders

Epilepsy

  1. Liu H, Yang Y, Wang Y, et al. Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies. Epilepsia Open. 2018;3(1):9-17. doi:10.1002/epi4.12098 
  2. van Berkel AA, IJff DM, Verkuyl JM. Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview. Epilepsy Behav. 2018;87:69-77. doi:10.1016/j.yebeh.2018.06.004 
  3. Ye F, Li X-J, Jiang W-L, Sun H-B, Liu J. Efficacy of and Patient Compliance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-Analysis. Journal of Clinical Neurology. 2015;11(1):26-31. doi:10.3988/jcn.2015.11.1.26 
  4. Nei M, Ngo L, Sirven JI, Sperling MR. Ketogenic diet in adolescents and adults with epilepsy. Seizure – European Journal of Epilepsy. 2014;23(6):439-442. doi:10.1016/j.seizure.2014.02.015 
  5. Shah LM, Turner Z, Bessone SK, Winesett SP, Stanfield A, Kossoff EH. How often is antiseizure drug-free ketogenic diet therapy achieved? Epilepsy Behav. 2019;93:29-31.  doi:10.1016/j.yebeh.2019.01.042 
  6. Sadeghifar F, Penry VB. Mechanisms and Uses of Dietary Therapy as a Teatment for Epilepsy: A Review. Glob Adv Health Med. 2019;8. doi:10.1177/2164956119874784 
  7. Wells J, Swaminathan A, Paseka J, Hanson C. Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy—A Review. Nutrients. 2020;12(6):1809. doi:10.3390/nu12061809
  8. Zarnowska IM. Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned. Nutrients. 2020;12(9):2616. doi:10.3390/nu12092616
  9. Verrotti A, Iapadre G, Di Francesco L, Zagaroli L, Farello G. Diet in the Treatment of Epilepsy: What We Know So Far. Nutrients. 2020;12(9):2645. doi:10.3390/nu12092645
  10. Hettiarachchi D, Lakmal K, Dissanayake VHW. A Concise Review of Ketogenic Dietary Interventions in the Management of Rare Diseases. Journal of Nutrition and Metabolism. doi:https://doi.org/10.1155/2021/6685581

Epilepsy - Children and Infants

  1. Sourbron J, Klinkenberg S, van Kuijk SMJ, et al. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. Childs Nerv Syst. Published online March 16, 2020. doi:10.1007/s00381-020-04578-7
  2. Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. n/a(n/a). doi:10.1111/epi.16543
  3. Liu XY, Chen J, Zhu M, et al. Three and Six Months of Ketogenic Diet for Intractable Childhood Epilepsy: A Systematic Review and Meta-Analysis. Front Neurol. 2019;10:244. doi:10.3389/fneur.2019.00244 
  4. Cai Q-Y, Zhou Z-J, Luo R, et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017;13(6):528-536. doi:10.1007/s12519-017-0053-2 
  5. Kim SH, Shaw A, Blackford R, et al. The ketogenic diet in children 3 years of age or younger: A 10-year single-center experience. Scientific Reports. 2019;9(1):8736. doi:10.1038/s41598-019-45147-6
  6. Luz IR, Pereira C, Garcia P, et al. Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre. Acta Médica Portuguesa. 2019;32(12):760-766. doi:10.20344/amp.12184  PDF
  7. Le Pichon JB, Thompson L, Gustafson M, Abdelmoity A. Initiating the ketogenic diet in infants with treatment refractory epilepsy while maintaining a breast milk diet. Seizure. 2019;69:41-43. doi:10.1016/j.seizure.2019.03.017 
  8. Dressler A, Trimmel-Schwahofer P. The ketogenic diet for infants: How long can you go? Epilepsy Res. 2020;164:106339. doi:10.1016/j.eplepsyres.2020.106339 ABSTRACT
  9. Wirrell E, Eckert S, Wong-Kisiel L, Payne E, Nickels K. Ketogenic Diet Therapy in Infants: Efficacy and Tolerability. Pediatr Neurol. 2018;82:13-18. doi:10.1016/j.pediatrneurol.2017.10.018
  10. Sharma S, Goel S, Kapoor D, et al. Evaluation of the Modified Atkins Diet for the Treatment of Epileptic Spasms Refractory to Hormonal Therapy: A Randomized Controlled Trial. J Child Neurol. Published online April 9, 2021:8830738211004747. doi:10.1177/08830738211004747
  11. Zhang J, Chen G, Wang J, et al. Efficacy of the ketogenic diet on ACTH- or corticosteroid-resistant infantile spasm: a multicentre prospective control study. Epileptic Disord. Published online March 26, 2021. doi:10.1684/epd.2021.1256
  12. Lin K-L, Lin J-J, Wang H-S. Application of ketogenic diets for pediatric neurocritical care. Biomedical Journal. Published online July 5, 2020. doi:10.1016/j.bj.2020.02.002

Potential Complications/Growth

  1. Mir A, Albaradie R, Alamri A, et al. Incidence of potential adverse events during hospital‐based ketogenic diet initiation among children with drug‐resistant epilepsy. Epilepsia Open. 2020;5(4):596-604. doi:10.1002/epi4.12442 
  2. Ferraris C, Guglielmetti M, Pasca L, et al. Impact of the Ketogenic Diet on Linear Growth in Children: A Single-Center Retrospective Analysis of 34 Cases. Nutrients. 2019;11(7). doi:10.3390/nu11071442
  3. Liu Y, Wan J, Gao Z, Xu L, Kong L. Ketogenic diet and growth in Chinese infants with refractory epilepsy. Asia Pac J Clin Nutr. 2021;30(1):113-121. doi:10.6133/apjcn.202103_30(1).0014 ABSTRACT

Status Epilepticus

  1. Schoeler NE, Simpson Z, Zhou R, Pujar S, Eltze C, Cross JH. Dietary Management of Children With Super-Refractory Status Epilepticus: A Systematic Review and Experience in a Single UK Tertiary Centre. Front Neurol. 2021;12. doi:10.3389/fneur.2021.643105
  2. Mahmoud SH, Ho‐Huang E, Buhler J. Systematic review of ketogenic diet use in adult patients with status epilepticus. Epilepsia Open. 2020;5(1):10-21. doi:10.1002/epi4.12370
  3. Williams TJ, Cervenka MC. The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin Neurophysiol Pract. 2017;2:154-160. doi:10.1016/j.cnp.2017.06.001
  4. Katz JB, Owusu K, Nussbaum I, et al. Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist. Journal of Clinical Medicine. 2021;10(4):881. doi:10.3390/jcm10040881
  5. Noviawaty I, Olaru E, Rondello C, Fitzsimmons B, Raghavan M. Clinical Reasoning: Ketogenic diet in adult super-refractory status epilepticus. Neurology. Published online February 27, 2020:10.1212/WNL.0000000000009137. doi:10.1212/WNL.0000000000009137

Autism Spectrum Disorder

  1. Castro K, Faccioli LS, Baronio D, Gottfried C, Perry IS, dos Santos Riesgo R. Effect of a ketogenic diet on autism spectrum disorder: A systematic review. Research in Autism Spectrum Disorders. 2015;20:31-38. doi:10.1016/j.rasd.2015.08.005 ABSTRACT
  2. Lee RWY, Corley MJ, Pang A, et al. A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder. Physiol Behav. 2018;188:205-211. doi:10.1016/j.physbeh.2018.02.006  PDF 
  3. El-Rashidy O, El-Baz F, El-Gendy Y, Khalaf R, Reda D, Saad K. Ketogenic diet versus gluten free casein free diet in autistic children: a case-control study. Metab Brain Dis. 2017;32(6):1935-1941. doi:10.1007/s11011-017-0088-z ABSTRACT
  4. Frye RE. Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments. Seminars in Pediatric Neurology. 2020;35:100829. doi:10.1016/j.spen.2020.100829
  5. Żarnowska I, Chrapko B, Gwizda G, Nocuń A, Mitosek-Szewczyk K, Gasior M. Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings. Metab Brain Dis. 2018;33(4):1187-1192. doi:10.1007/s11011-018-0219-1
  6. Evangeliou A, Vlachonikolis I, Mihailidou H, et al. Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study. J Child Neurol. 2003;18(2):113-118. doi:10.1177/08830738030180020501 ABSTRACT 
  7. Herbert MR, Buckley JA. Autism and Dietary Therapy: Case Report and Review of the Literature. J Child Neurol. 2013;28(8):975-982. doi:10.1177/0883073813488668 ABSTRACT
  8. Kawicka A, Regulska-Ilow B. How nutritional status, diet and dietary supplements can affect autism. A review. Rocz Panstw Zakl Hig. 2013;64(1):1-12. PMID: 23789306   PDF
  9. Cheng N, Rho JM, Masino SA. Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Front Mol Neurosci. 2017;10. doi:10.3389/fnmol.2017.00034  mechanistic
  10. Napoli E, Dueñas N, Giulivi C. Potential Therapeutic Use of the Ketogenic Diet in Autism Spectrum Disorders. Front Pediatr. 2014;2. doi:10.3389/fped.2014.00069

Neuro-degenerative

General

  1. Włodarek D. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease). Nutrients. 2019;11(1). doi:10.3390/nu11010169
  2. Gyorkos A, Baker MH, Miutz LN, Lown DA, Jones MA, Houghton-Rahrig LD. Carbohydrate-restricted Diet and Exercise Increase Brain-derived Neurotrophic Factor and Cognitive Function: A Randomized Crossover Trial. Cureus. 11(9). doi:10.7759/cureus.5604
  3. Fortier M, Castellano C-A, St‐Pierre V, et al. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT. Alzheimer’s & Dementia. n/a(n/a). doi:https://doi.org/10.1002/alz.12206
  4. Veyrat-Durebex C, Reynier P, Procaccio V, et al. How Can a Ketogenic Diet Improve Motor Function? Front Mol Neurosci. 2018;11. doi:10.3389/fnmol.2018.00015
  5. Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014;2014:474296. doi:10.1155/2014/474296
  6. Yang H, Shan W, Zhu F, Wu J, Wang Q. Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms. Front Neurol. 2019;10. doi:10.3389/fneur.2019.00585
  7. Vinciguerra F, Graziano M, Hagnäs M, Frittitta L, Tumminia A. Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review. Nutrients. 2020;12(4):1019. doi:10.3390/nu12041019
  8. Mujica-Parodi LR, Amgalan A, Sultan SF, et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. PNAS. 2020;117(11):6170-6177. doi:10.1073/pnas.1913042117
  9. Camandola S, Mattson MP. Brain metabolism in health, aging, and neurodegeneration. The EMBO Journal. 2017;36(11):1474-1492. doi:10.15252/embj.201695810
  10. Morris G, Maes M, Berk M, Carvalho AF, Puri BK. Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders. European Psychiatry. 2020;63(1). doi:10.1192/j.eurpsy.2019.13
  11. Mujica-Parodi LR, Amgalan A, Sultan SF, et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. PNAS. 2020;117(11):6170-6177. doi:10.1073/pnas.1913042117
  12. Norwitz NG, Jaramillo JG, Clarke K, Soto A. Chapter Six – Ketotherapeutics for neurodegenerative diseases. In: Söderbom G, Esterline R, Oscarsson J, Mattson MP, eds. International Review of Neurobiology. Vol 155. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating neurodegenerative diseases as metabolic diseases. Academic Press; 2020:141-168. doi:10.1016/bs.irn.2020.02.003   PDF
  13. Maiuolo J, Gliozzi M, Musolino V, et al. From Metabolic Syndrome to Neurological Diseases: Role of Autophagy. Front Cell Dev Biol. 2021;9. doi:10.3389/fcell.2021.651021
  14. Phillips MCL, Murtagh DKJ, Ziad F, Johnston SE, Moon BG. Impact of a Ketogenic Diet on Sporadic Inclusion Body Myositis: A Case Study. Front Neurol. 2020;11. doi:10.3389/fneur.2020.582402
  15. Höller A, Albrecht U, Baumgartner Sigl S, et al. Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C. Molecular Genetics and Metabolism Reports. 2021;27:100723. doi:10.1016/j.ymgmr.2021.100723

Alzheimer's Disease

  1. Phillips MCL, Deprez LM, Mortimer GMN, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimer’s Research & Therapy. 2021;13(1):51. doi:10.1186/s13195-021-00783-x
  2. Lilamand M, Porte B, Cognat E, Hugon J, Mouton-Liger F, Paquet C. Are ketogenic diets promising for Alzheimer’s disease? A translational review. Alzheimer’s Research & Therapy. 2020;12(1):42. doi:10.1186/s13195-020-00615-4
  3. Ota M, Matsuo J, Ishida I, et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neuroscience Letters. 2019;690:232-236. doi:10.1016/j.neulet.2018.10.048 
  4. Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer’s disease. Alzheimers Dement (N Y). 2017;4:28-36. doi:10.1016/j.trci.2017.11.002
  5. Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Ketogenic Diet in Alzheimer’s Disease. International Journal of Molecular Sciences. 2019;20(16):3892. doi:10.3390/ijms20163892
  6. Pinto A, Bonucci A, Maggi E, Corsi M, Businaro R. Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease. Antioxidants (Basel). 2018;7(5). doi:10.3390/antiox7050063
  7. Taylor MK, Swerdlow RH, Burns JM, Sullivan DK. An Experimental Ketogenic Diet for Alzheimer Disease Was Nutritionally Dense and Rich in Vegetables and Avocado. Curr Dev Nutr. 2019;3(4):nzz003. doi:10.1093/cdn/nzz003
  8. Cunnane SC, Courchesne-Loyer A, Vandenberghe C, et al. Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease. Front Mol Neurosci. 2016;9:53. doi:10.3389/fnmol.2016.00053
  9. Stoykovich S, Gibas K. APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study. Alzheimers Dement (Amst). 2019;11:264-269. doi:10.1016/j.dadm.2019.01.009
  10. Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012;33(2):425.e19-425.e27. doi:10.1016/j.neurobiolaging.2010.10.006
  11. Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL. A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer’s disease. Alzheimer’s & Dementia. 2015;11(1):99-103. doi:10.1016/j.jalz.2014.01.006
  12. Taylor MK, Swerdlow RH, Sullivan DK. Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality. Nutrients. 2019;11(8):1910. doi:10.3390/nu11081910
  13. Rhea EM, Raber J, Banks WA. ApoE and cerebral insulin: Trafficking, receptors, and resistance. Neurobiology of Disease. 2020;137:104755. doi:10.1016/j.nbd.2020.104755
  14. Horner S, Berger L, Gibas K. Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer’s disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report. Photodiagnosis Photodyn Ther. Published online April 16, 2020:101777. doi:10.1016/j.pdpdt.2020.101777
  15. Berlanga-Acosta J, Guillén-Nieto G, Rodríguez-Rodríguez N, et al. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review. Front Endocrinol. 2020;11. doi:10.3389/fendo.2020.560375

Media Links

  1. Ivor Cummins – Youtube – Ep50 Dale Bredesen MD “The End Of Alzheimer’s” – Prevention and Resolution!

Amyotrophic Lateral Sclerosis

  1. Caplliure‐Llopis J, Peralta‐Chamba T, Carrera‐Juliá S, et al. Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review. Food Sci Nutr. 2019;8(1):23-35. doi:10.1002/fsn3.1324
  2. Paganoni S, Wills A-M. High-Fat and Ketogenic Diets in Amyotrophic Lateral Sclerosis. J Child Neurol. 2013;28(8):989-992. doi:10.1177/0883073813488669   PDF 
  3. Zhao Z, Lange DJ, Voustianiouk A, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29. doi:10.1186/1471-2202-7-29

Parkinson’s Disease

  1. Krikorian R, Shidler MD, Summer SS, et al. Nutritional ketosis for mild cognitive impairment in Parkinson’s disease: A controlled pilot trial. Clinical Parkinsonism & Related Disorders. August 2019. doi:10.1016/j.prdoa.2019.07.006
  2. Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-fat versus ketogenic diet in Parkinson’s disease: A pilot randomized controlled trial. Mov Disord. 2018;33(8):1306-1314. doi:10.1002/mds.27390
  3. Norwitz NG, Dearlove DJ, Lu M, Clarke K, Dawes H, Hu MT. A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease. Front Neurosci. 2020;14. doi:10.3389/fnins.2020.584130
  4. Koyuncu H, Fidan V, Toktas H, Binay O, Celik H. Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson’s disease. Acta Neurol Belg. Published online September 6, 2020. doi:10.1007/s13760-020-01486-0 ABSTRACT
  5. Norwitz NG, Hu MT, Clarke K. The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson’s Disease. Front Nutr. 2019;6. doi:10.3389/fnut.2019.00063
  6. Thickbroom GW. The therapeutic potential of ketone bodies in Parkinson’s disease. Expert Review of Neurotherapeutics. 2021;0(0):1-3. doi:10.1080/14737175.2021.1881483
  7. Jabre MG, Bejjani B-PW. Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study. doi:org/10.1212/01.WNL.0000152046.11390.45   PDF  Comment
  8. Fiory F, Perruolo G, Cimmino I, et al. The Relevance of Insulin Action in the Dopaminergic System. Front Neurosci. 2019;13. doi:10.3389/fnins.2019.00868

Multiple Sclerosis

  1. Bock M, Michalsen A, Paul F. Ketogenic diet and prolonged fasting improve health-related quality of life and lipid profiles in multiple sclerosis –A randomized controlled trial. In: ; 2015. PDF
  2. Benlloch M, López-Rodríguez MM, Cuerda-Ballester M, et al. Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients. 2019;11(5):1156. doi:10.3390/nu11051156
  3. Brenton JN, Banwell B, Bergqvist AGC, et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e565. doi:10.1212/NXI.0000000000000565
  4. Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1-18. doi:10.2147/DNND.S116949
  5. Bock M, Karber M, Kuhn H. Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis. EBioMedicine. 2018;36:293-303. doi:10.1016/j.ebiom.2018.08.057
  6. Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet. Front Microbiol. 2017;8. doi:10.3389/fmicb.2017.01141
  7. Lee JE, Bisht B, Hall MJ, et al. A Multimodal, Nonpharmacologic Intervention Improves Mood and Cognitive Function in People with Multiple Sclerosis. Journal of the American College of Nutrition. 2017;36(3):150-168. doi:10.1080/07315724.2016.1255160
  8. Fellows Maxwell K, Wahls T, Browne RW, et al. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. PLoS One. 2019;14(6). doi:10.1371/journal.pone.0218075
  9. Choi IY, Piccio L, Childress P, et al. Diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15(10):2136-2146. doi:10.1016/j.celrep.2016.05.009
  10. Storoni M, Plant GT. The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Multiple Sclerosis International. 2015. doi:10.1155/2015/681289
  11. Nathan J, Khedekar Kale D, Naik VD, Thakker F, Bailur S. Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report. Cureus. 2019;11(8):e5341. doi:10.7759/cureus.5341
  12. Wahls TL, Chenard CA, Snetselaar LG. Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic. Nutrients. 2019;11(2). doi:10.3390/nu11020352
  13. Maric G, Lalic K, Pekmezovic T, et al. Could the performance of oral glucose tolerance test contribute to the brain health-focused care in multiple sclerosis? Multiple Sclerosis and Related Disorders. 2020;46:102536. doi:10.1016/j.msard.2020.102536 ABSTRACT
  14. Bahr LS, Bock M, Liebscher D, et al. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study. Trials. 2020;21(1):3. doi:10.1186/s13063-019-3928-9 – Valuable background discussion

Media Links

  1. Dr Tommy Wood/Ragnar – Multiple Sclerosis – Meðferðaúræði við MS – YouTube (In English)

Neurology - Other

  1. Stafstrom CE, Rho JM. The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders. Front Pharmacol. 2012;3. doi:10.3389/fphar.2012.00059 
  2. Ruskin DN, Masino SA. The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy. Front Neurosci. 2012;6. doi:10.3389/fnins.2012.00033
  3. Tavarez T, Roehl K, Koffman L. Nutrition in the Neurocritical Care Unit: a New Frontier. Curr Treat Options Neurol. 2021;23(5). doi:10.1007/s11940-021-00670-8
  4. Watt C, Sanchez-Rangel E, Hwang JJ. Glycemic Variability and CNS Inflammation: Reviewing the Connection. Nutrients. 2020;12(12):3906. doi:10.3390/nu12123906
  5. Nathan J, Khedekar Kale D, Naik VD, Thakker F, Bailur S. Substantial Remission in Subacute Sclerosing Panencephalitis by Following the Ketogenic Diet: A Case Report. Cureus. 2019;11(8):e5485. doi:10.7759/cureus.5485
  6. Ulate-Campos A, Fons C, Artuch R, et al. Alternating Hemiplegia of Childhood With a de Novo Mutation in ATP1A3 and Changes in SLC2A1 Responsive to a Ketogenic Diet. Pediatric Neurology. 2014;50(4):377-379. doi:10.1016/j.pediatrneurol.2013.11.017
  7. Roubergue A, Philibert B, Gautier A, et al. Excellent Response to a Ketogenic Diet in a Patient with Alternating Hemiplegia of Childhood. JIMD Rep. 2014;15:7-12. doi:10.1007/8904_2013_292

Brain Injury/Neurotrauma

  1. Rippee MA, Chen J, Taylor MK. The Ketogenic Diet in the Treatment of Post-concussion Syndrome—A Feasibility Study. Front Nutr. 2020;7. doi:10.3389/fnut.2020.00160
  2. White H, Venkatesh B. Clinical review: Ketones and brain injury. Critical Care. 2011;15(2):219. doi:10.1186/cc10020
  3. Prins M. DIET, KETONES AND NEUROTRAUMA. Epilepsia. 2008;49(Suppl 8):111-113. doi:10.1111/j.1528-1167.2008.01852.x
  4. Wood TR, Stubbs BJ, Juul SE. Exogenous Ketone Bodies as Promising Neuroprotective Agents for Developmental Brain Injury. Dev Neurosci. May 2019:1-12. doi:10.1159/000499563
  5. Maiorana A, Manganozzi L, Barbetti F, et al. Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage. Orphanet J Rare Dis. 2015;10. doi:10.1186/s13023-015-0342-6
  6. Shaafi S, Mahmoudi J, Pashapour A, Farhoudi M, Sadigh-eteghad S, Akbari H. Ketogenic Diet Provides Neuroprotective Effects against Ischemic Stroke Neuronal Damages. Adv Pharm Bull. 2014;4(Suppl 2):479-481. doi:10.5681/apb.2014.071      PDF 
  7. White H, Venkatesh B, Jones M, Kruger PS, Walsham J, Fuentes H. Inducing ketogenesis via an enteral formulation in patients with acute brain injury:a phase II study. Neurological Research. 2020;0(0):1-11. doi:10.1080/01616412.2019.1709743
  8. Prins ML, Matsumoto JH. The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury. J Lipid Res. 2014;55(12):2450-2457. doi:10.1194/jlr.R046706 
  9. Chang Y, Kim CK, Kim M-K, Seo W-K, Oh K. Insulin resistance may affect the functional recovery of acute ischemic stroke in non-diabetic patients. Published online March 15, 2020. doi:10.21203/rs.3.rs-17241/v1
  10. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Research Reviews. 2009;59(2):293-315. doi:10.1016/j.brainresrev.2008.09.002    PDF 
  11. Yarar-Fisher C, Kulkarni A, Li J, et al. Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: a pilot, randomized safety and feasibility trial. Spinal Cord Ser Cases. 2018;4:88. doi:10.1038/s41394-018-0121-4 
  12. Arora N, Mehta TR. Role of the ketogenic diet in acute neurological diseases. Clinical Neurology and Neurosurgery. 2020;192:105727. doi:10.1016/j.clineuro.2020.105727
  13. Lin K-L, Lin J-J, Wang H-S. Application of ketogenic diets for pediatric neurocritical care. Biomedical Journal. Published online July 5, 2020. doi:10.1016/j.bj.2020.02.002
  14. Stubbs BJ, Koutnik AP, Volek JS, Newman JC. From bedside to battlefield: intersection of ketone body mechanisms in geroscience with military resilience. GeroScience. Published online October 2, 2020. doi:10.1007/s11357-020-00277-y
  15. Yarar-Fisher C, Li J, Womack ED, et al. Ketogenic regimens for acute neurotraumatic events. Curr Opin Biotechnol. 2021;70:68-74. doi:10.1016/j.copbio.2020.12.009
  16. Demirel A, Li J, Morrow C, et al. Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: study protocol for a randomized controlled trial. Trials. 2020;21(1):372. doi:10.1186/s13063-020-04273-7 – useful background/discussion
  17. D’Agostino CA, Zippert M, D’Agostino DP. Neuroregeneration improved by ketones. The FASEB Journal. 2018;32(S1):545.9-545.9. doi:10.1096/fasebj.2018.32.1_supplement.545.9 (Pre-clinical) ABSTRACT

Migraine/Headache

  1. Di Lorenzo C, Pinto A, Ienca R, et al. A Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones? Nutrients. 2019;11(8):1742. doi:10.3390/nu11081742
  2. Bongiovanni D, Benedetto C, Corvisieri S, et al. Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine. Neurol Sci. Published online February 1, 2021. doi:10.1007/s10072-021-05078-5
  3.  Di Lorenzo C, Coppola G, Bracaglia M, et al. A ketogenic diet normalizes interictal cortical but not subcortical responsivity in migraineurs. BMC Neurol. 2019;19(1):136. doi:10.1186/s12883-019-1351-1    PDF
  4. Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache. 2020;60(7):1300-1316. doi:10.1111/head.13836
  5. Cannataro R, Perri M, Caroleo MC, Gallelli L, Sarro GD, Cione E. Modulation of MicroRNAs Linked to Pain-migraine by Ketogenic Diet (P14-007-19). Current Developments in Nutrition. 2019;3(Supplement_1):nzz052.P14-007-19. doi:10.1093/cdn/nzz052.P14-007-19    PDF
  6. Di Lorenzo C, Coppola G, Bracaglia M, et al. Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study. J Headache Pain. 2016;17. doi:10.1186/s10194-016-0650-9
  7. Di Lorenzo C, Coppola G, Di Lenola D, et al. Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial. Front Neurol. 2018;9:64. doi:10.3389/fneur.2018.00064
  8. Gross EC, Klement RJ, Schoenen J, D’Agostino DP, Fischer D. Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention. Nutrients. 2019;11(4). doi:10.3390/nu11040811
  9. Lorenzo CD, Coppola G, Sirianni G, Pierelli F. Short term improvement of migraine headaches during ketogenic diet: a prospective observational study in a dietician clinical setting. 2017.PDF
  10. Farkas MK, Mak E, Richter E, Farkas V. EHMTI-0336. Metabolic diet therapy in the prophylactic treatment of migraine headache in adolescents by using ketogenic diet. 2014. PDF
  11. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M, On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS). Association of diet and headache. The Journal of Headache and Pain. 2019;20(1):106. doi:10.1186/s10194-019-1057-1
  12. Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M. Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci. 2017;38(1):111-115. doi:10.1007/s10072-017-2889-6 ABSTRACT
  13. Di Lorenzo C, Coppola G, Sirianni G, et al. Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol. 2015;22(1):170-177. doi:10.1111/ene.12550
  14. Raucci U, Boni A, Evangelisti M, et al. Lifestyle Modifications to Help Prevent Headache at a Developmental Age. Front Neurol. 2021;11. doi:10.3389/fneur.2020.618375
  15. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007;47(10):1436-1442. doi:10.1111/j.1526-4610.2007.00719.x ABSTRACT

Media Links

  1. Podcast LCM. Low Carb MD Podcast – Episode 135: Dr. Josh Turknett. Google Podcasts.

Updated 01 April 2021

© 2020 The Nutrition Network. All rights reserved.

Latest Update: 01 April 2021